 |
A
new addition to the HEART is our
Forum-check
it out
|
"This report updates and consolidates all previous
U.S. Public Health Service recommendations for the management of
health-care personnel (HCP) who have occupational exposure to blood
and other body fluids that might contain hepatitis B virus HBV),
hepatitis C virus (Hepatitis C Virus), or human immunodeficiency virus (HIV).
Recommendations for HBV postexposure management include initiation
of the hepatitis B vaccine series to any susceptible, unvaccinated
person who sustains an occupational blood or body fluid exposure.
Postexposure prophylaxis (PEP) with hepatitis B immune globulin
(HBIG) and/or hepatitis B vaccine series should be considered for
occupational exposures after evaluation of the hepatitis B surface
antigen status of the source and the vaccination and vaccine-response
status of the exposed person. Guidance is provided to clinicians
and exposed HCP for selecting the appropriate HBV PEP.
Immune globulin and antiviral agents (e.g., interferon with or
without ribavirin) are not recommended for PEP of hepatitis C. For
Hepatitis C Virus postexposure management, the Hepatitis C Virus status of the source and the
exposed person should be determined, and for HCP exposed to an Hepatitis C Virus
positive source, follow-up Hepatitis C Virus testing should be performed to determine
if infection develops.
Recommendations for HIV PEP include a basic 4-week regimen of two
drugs (zidovudine [ZDV] and lamivudine [3TC]; 3TC and stavudine
[d4T]; or didanosine [ddI] and d4T) for most HIV exposures and an
expanded regimen that includes the addition of a third drug for
HIV exposures that pose an increased risk for transmission. When
the source person's virus is known or suspected to be resistant
to one or more of the drugs considered for the PEP regimen, the
selection of drugs to which the source person's virus is unlikely
to be resistant is recommended.
In addition, this report outlines several special circumstances
(e.g., delayed exposure report, unknown source person, pregnancy
in the exposed person, resistance of the source virus to antiretroviral
agents, or toxicity of the PEP regimen) when consultation with local
experts and/or the National Clinicians' Post-Exposure Prophylaxis
Hotline ([PEPline] 1-888-448-4911) is advised.
Occupational exposures should be considered urgent medical concerns
to ensure timely postexposure management and administration of HBIG,
hepatitis B vaccine, and/or HIV." Guidelines for the Management
of Occupational Exposures to HBV, Hepatitis C Virus, and HIV and Recommendations
for Postexposure Prophylaxis
ADDITIONAL ARTICLES:
|
Document Name & Link to Document
|
Description
|
File Size /Type**
|
|
14 Ways to
Guarantee That Your Long-Term Disability insurance Claim is
Denied and you Lose in Court |
Reason for
report-“I am sick and tired of seeing people lose their chance
at getting disability benefits because they didn’t know (and the
insurance company won’t tell them) the traps they can easily
fall into.” |
3,111 kb pdf |
|
A WAITING ROOM OF
THEIR OWN: THE FAMILY CARE NETWORK AS A MODEL FOR PROVIDING
GENDER-SPECIFIC LEGAL SERVICES TO WOMEN WITH HIV |
As the fastest growing segment of the HIV epidemic in the
United States, women with HIV have substantial needs for
services, including legal services, many of which go unmet.
HIV-infected women face numerous, varied, and
[*pg 104]
complex gender-specific barriers that prevent them from
accessing legal services at the rate and in the manner that
they would in the absence of such barriers. |
|
|
|
|
AIDS
LEGAL BIBLIOGRAPHY |
A compilation of articles and books concerning legal issues
surrounding the AIDS Epidemic published before June 11, 1998
|
|
|
Care Act- Ryan White Comprehensive AIDS Resources Emergency
Act
|
The Ryan
White Comprehensive AIDS Resources Emergency (CARE)1 Act is
the single largest federal program designed specifically for
people with HIV/AIDS. First enacted in 1990, and
reauthorized in 1996 and 2000, the CARE Act provides care
and support services to individuals and families affected by
HIV/AIDS, functioning as the “payer of last resort,” that
is, it fills the gaps in care for those who have no other
source of coverage or face coverage limits. Federal CARE Act
funding is provided to cities, states, 2 and directly to
providers and other organizations. |
Pdf 220 kb |
|
Funding Streams Report 2002-Boston |
This
report describes the types and amounts of federal, state, and
local funds available for HIV-related services in the Boston
Eligible Metropolitan Area as reported in April 2002. |
753 kb pdf |
|
HIV/AIDS in Dental Care |
A
case-based self-study module for dental health care
personnel |
533 kb pdf |
|
HIV Testing During Pregnancy: The Value of Optimizing
Consent |
The
issues of patient autonomy and informed decision making are at
the center of the debate over appropriate standards for HIV
testing during pregnancy. State law standards on this issue
vary significantly from state to state. Federal policy
pronouncements on this issue also lack consistency. Against
this legal and policy background, the two articles in this
Special Section of AIDS & Public Policy Journal present
a significant lesson for policy makers: patients value their
decision making autonomy very highly in regard to HIV testing,
and that value can be respected while at the same time
achieving high rates of testing. Optimizing consent enhances
the provider-patient relationship, a critically important
relationship for a pregnant woman with HIV infection. Laws and
policies that disfavor patients' consent, such as mandatory
newborn testing laws, have little justification and should be
rejected by policy makers. |
|
|
Housing Assistance For Disabled Persons With Modest Incomes |
There are
at least eight kinds of housing aid programs financed by the
federal Department of Housing and Urban Development (HUD),
the Internal Revenue Service (IRS), the Department of
Agriculture (DoA), the Department of Health and Human
Services (HHS) and the Department of Energy (DoE): |
|
|
Legal Resources for People with HIV/AIDS, Directory of
|
This report is
intended to serve at least three primary purposes: first and
foremost, to assist persons affected by HIV or AIDS who are
seeking legal services; second, to provide sources of
information concerning how to develop pro bono programs
focusing on legal issues related to the epidemic; and third,
to be a resource for attorneys seeking to become involved with
pro bono representation in these areas. |
1517 kb
pdf |
|
Recommendations for
Prevention and Control of Hepatitis C infections and Hepatitis C-related Chronic
Disease
|
Report from the CDC
|
490 kb pdf
|
|
Updated
U.S. Public Health Service Guidelines for the Management of
Occupational Exposures to Hepatitis B, Hepatitis C, and HIV and Recommendations
for Postexposure Prophylaxis: June 2001
|
This report updates and consolidates all previous
U.S. Public Health Service recommendations for the management
of health-care personnel (HCP) who have occupational exposure
to blood and other body fluids thatmight contain hepatitis
B virus (HBV), hepatitis C virus (Hepatitis C Virus), or human immunodeficiency
virus (HIV). Recommendations for HBV postexposure management
include initiation of the hepatitis B vaccine series to any
susceptible, unvaccinated person who sustains an occupational
blood or body fluid exposure
|
|
** In order to view PDF files, you must have Adobe Acrobat Reader installed on
your computer. Many computers already have this software; however, if you need
it, a free copy is available for download at this site: Click
here to get Adobe Acrobat Reader.
|